CIK 0001133416
- Non-accelerated filer
- Smaller reporting company
GALECTIN THERAPEUTICS INC
Sign in to watch- Ticker
- GALT
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- NV
- Entity type
- Operating
- EIN
- 043562325
- Phone
- +1 678-620-3186
- Business address
- 4960 PEACHTREE INDUSTRIAL BOULEVARD, SUITE 240, NORCROSS, GA, 30071
- Former names
- PRO PHARMACEUTICALS INC
- 4 Grant or award President and CEO acquired 3,940 shares (grant or award)
- 4/A Open-market sale 10% owner sold 37,500 shares at an average $4.25 ($159,475)
- 4 Open-market sale 10% owner sold 27,500 shares at an average $3.97 ($109,275)
- 4 Grant or award President and CEO acquired 3,771 shares (grant or award)
- 4 Derivatives Options or other derivatives
- 4 Grant or award President and CEO acquired 7,474 shares (grant or award)
- 4 Open-market buy Director bought 5,000 shares at $2.04 ($10,200)
- 4 Open-market sale 10% owner sold 10,000 shares at $2.16 ($21,600)
- 4 Grant or award President and CEO acquired 7,680 shares (grant or award)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
Page 13 of 39 · 776 filings